SPOTLIGHT -
Top 200 generic drugs in 2003 by units
Oncology Drug Exkivity to be Voluntarily Withdrawn From US Market
Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Gut Health Has Impact on the Skin
The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.
RPhCast, Episode Four: Finding Satisfaction In A Pharmacy Career
Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.
NDA for Investigational Schizophrenia Treatment Submitted to FDA
The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
Novel Self-Amplifying mRNA Vaccine Demonstrates Robust, Durable Immune Response
Vaccines were tested against various strains of the SARS-CoV-2 virus.
